ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
- Understand the correct way to take a history in a patient presenting with a first seizure
- Explain the alternative diagnoses in a patient presenting with “episodes”
- Understand the availability of tools for proper diagnosis of epilepsy patients
Presenter(s)
Jacqueline French, MD
Professor of Neurology
NYU Langone Epilepsy Center
Chief Medical/Innovation Officer of the Epilepsy Foundation
Director of the Epilepsy Study Consortium
All persons in control of content have NO relevant financial relationships to disclosure except:
In accordance with the ACCME® standard for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.
Name | Company | Role |
Jacqueline French, MD | Epilepsy Foundation
| Chief Medical/Innovation Officer |
Jacqueline French, MD | Aeonian/Aeovian, Anavex, Arvelle Therapeutics, Inc., Athenen Therapeutics/Carnot Pharma, Axovant, Biogen, BioXcel Therapeutics, Blackfynn, Cerebral Therapeutics, Cerevel, Crossject, CuroNZ, Eisai, Encoded Therapeutics, Engage Therapeutics, Epiminder, Epitel, Fortress Biotech, Greenwich Biosciences, GW Pharma, Ionis, Janssen Pharmaceutica, Knopp Biosciences, Lundbeck, Marinus, Merck, NeuCyte, Inc., Neurocrine, Otsuka Pharmaceutical Development, Ovid Therapeutics Inc., Passage Bio, Pfizer, Praxis, Redpin, Sage, SK Life Sciences, Stoke, Sunovion, Supernus, Takeda, UCB Inc., Xenon, Xeris, Zogenix | Scientific Advisory Board |
Jacqueline French, MD | Biogen, Cavion, Eisai, Engage, GW Pharma, Lundbeck, Neurelis, Ovid, Pfizer, SK Life Sciences, Sunovion, UCB, Xenon and Zogenix Epilepsy Research Foundation, Epilepsy Study Consortium, and NINDS | Research Grant |
Jacqueline French, MD | Lancet Neurology and Neurology Today | Editorial Board |
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.